Silvia Zaragoza Domingo, PhD’s Post

ISCTM 2023 Autumn Conference joint day with European College of Neuropsychopharmacology (ECNP) held on 5-7 October 2023 in Barcelona, Spain. It was a real pleasure to participate as panelist during the discussion at Session 3: Are our clinician rated psychopathology measures fit for purpose decades later? Chairs: Nina Schooler Celso Arango Stephen Marder Participants: koen demyttenaere, Eduard Vieta, Vikas Mohan Sharma and Alex Cohen. "Most of the measures of psychopathology that we currently use have been in place for decades and some for more than half a century. (...) However, these older measures have not been informed by recent advances in the understanding of psychopathology and all of them rely on a subject’s recollection of symptoms during a defined time period." The recognition of the weakness of this existing instruments made by experts, is the first step towards its improvement, opening the room to innovative solutions. It is relevant to stablish what is needed to be measured in clinical research and to develop the best tool for the context of application of any new treatment. All this relevant work needs to be done years in advance when planning for a new drug development. It was a great opportunity to be the voice of the Thematic Working Group at the ECNP focused on Outcomes Research in Early-phase Clinical Trials, and express the need to follow standard processes and that pre-competitive approaches nowadays represent an optimal scenario to work for advancing in the science of outcomes for clinical trials in neurosciences. It is always a great experience and pleasure to participate in @ISCTM and @ECNP working groups and events. #COA #ClinicalTrials #Neurosciences #CNS #psychiatry #neurology